Shukra Pharmaceuticals P/B Ratio
Shukra Pharmaceuticals (SHUKRAPHAR) P/B ratio is 14.7 (High), book value per share ₹20.45 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. View SHUKRAPHAR 52-week chart for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SHUKRAPHAR P/B Ratio — Valuation Insights & Book Value Analysis
Shukra Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 14.7 (High). Compare with SHUKRAPHAR fundamental valuation to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 14.7, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1160.7% above historical average
- Trading at premium to sector average PB of -0.33
Shukra Pharmaceuticals P/B Ratio Historical Trend
SHUKRAPHAR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SHUKRAPHAR share price.
SHUKRAPHAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Shukra Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.37 | ₹20.45 | ₹28.09 | ₹90 | Moderate |
| 2025 | 4.14 | ₹14.32 | ₹59.25 | ₹63 | High |
| 2024 | 0.26 | ₹52.73 | ₹13.65 | ₹58 | Low |
| 2023 | 0.05 | ₹62.5 | ₹3.10 | ₹25 | Low |
| 2022 | 0.01 | ₹80.0 | ₹0.70 | ₹16 | Low |
SHUKRAPHAR vs Healthcare Peers — P/B Ratio Comparison
Shukra Pharmaceuticals P/B 14.7 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |